These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11324316)

  • 1. [Role of nitric oxide in heart failure].
    Le Corvoisier P; Lopes ME; Su J; Hittinger L
    J Soc Biol; 2000; 194(3-4):143-9. PubMed ID: 11324316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial function and dysfunction in heart failure.
    Ferrari R; Bachetti T; Agnoletti L; Comini L; Curello S
    Eur Heart J; 1998 Jul; 19 Suppl G():G41-7. PubMed ID: 9717055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nitric oxide and heart failure].
    Yoshioka T; Takahashi M; Ikeda U
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():527-30. PubMed ID: 15506442
    [No Abstract]   [Full Text] [Related]  

  • 4. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular protection: current possibilities and future perspectives.
    Lüscher TF
    Int J Clin Pract Suppl; 2001 Jan; (117):3-6. PubMed ID: 11715356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin-converting enzyme inhibitor therapy.
    Morawietz H; Rohrbach S; Rueckschloss U; Schellenberger E; Hakim K; Zerkowski HR; Kojda G; Darmer D; Holtz J
    Eur J Clin Invest; 2006 Oct; 36(10):705-12. PubMed ID: 16968466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts.
    Egi K; Conrad NE; Kwan J; Schulze C; Schulz R; Wildhirt SM
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):262-9. PubMed ID: 15296881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endothelial function in coronary atherosclerosis and heart failure--the role of nitric oxide in regulation of vasomotor tone].
    Andreassen AK; Kirkebøen KA
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4066-9. PubMed ID: 10613099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endothelial dysfunction in cardial failure: potential mechanisms].
    Varin R; Mulder P; Richard V; Thuillez C
    Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():29-34. PubMed ID: 9515111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise training and endothelial dysfunction in coronary artery disease and chronic heart failure. From molecular biology to clinical benefits.
    Gielen S; Erbs S; Schuler G; Hambrecht R
    Minerva Cardioangiol; 2002 Apr; 50(2):95-106. PubMed ID: 12032463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nitric oxide during coronary endothelial dysfunction after myocardial infarction.
    Berges A; Van Nassauw L; Timmermans JP; Vrints C
    Eur J Pharmacol; 2005 May; 516(1):60-70. PubMed ID: 15923002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure.
    Tousoulis D; Charakida M; Stefanadis C
    Int J Cardiol; 2005 Apr; 100(3):347-53. PubMed ID: 15837076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure, platelet activation and inhibition of the renin-angiotensin-aldosterone system.
    Bauersachs J; Schäfer A
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):889-93. PubMed ID: 15521482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endothelium and the renin-angiotensin system.
    Holtz J; Goetz RM
    Arzneimittelforschung; 1994 Mar; 44(3A):397-402. PubMed ID: 8185713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pulsatile shear stress on signaling mechanisms controlling nitric oxide production, endothelial nitric oxide synthase phosphorylation, and expression in ovine fetoplacental artery endothelial cells.
    Li Y; Zheng J; Bird IM; Magness RR
    Endothelium; 2005; 12(1-2):21-39. PubMed ID: 16036314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells.
    Zhao X; Li X; Trusa S; Olson SC
    Regul Pept; 2005 Dec; 132(1-3):113-22. PubMed ID: 16242794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pulsatile shear stress on nitric oxide production and endothelial cell nitric oxide synthase expression by ovine fetoplacental artery endothelial cells.
    Li Y; Zheng J; Bird IM; Magness RR
    Biol Reprod; 2003 Sep; 69(3):1053-9. PubMed ID: 12773424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of inducible and endothelial nitric oxide synthase in porcine ovaries and effects of NO on antrum formation and oocyte meiotic maturation.
    Tao Y; Fu Z; Zhang M; Xia G; Yang J; Xie H
    Mol Cell Endocrinol; 2004 Jul; 222(1-2):93-103. PubMed ID: 15249129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase.
    Kinugawa S; Huang H; Wang Z; Kaminski PM; Wolin MS; Hintze TH
    Circ Res; 2005 Feb; 96(3):355-62. PubMed ID: 15637297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac myocyte neuronal nitric oxide synthase. New therapeutic target in heart failure?
    Loyer X; Samuel JL; Heymes C
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1244-8. PubMed ID: 16435605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.